| View |
|
DRP-5873-04
|
Escitalopram (as Oxalate)
|
Escitagrand 10
|
10 mg
|
Film-Coated Tablet
|
Antidepressant (Selective Serotonin Reuptake Inhibitor)
|
Ravian Life Science Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
03 December 2024
|
| View |
|
DRP-5873-05
|
Escitalopram(as oxalate)
|
Shepram
|
10 mg
|
Film-Coated Tablet
|
Antidepressant (Selective Serotonin Reuptake Inhibitor)
|
Ravian Life Science Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 March 2024
|
03 December 2024
|
| View |
|
DRP-5875-03
|
Escitalopram (as Oxalate)
|
Escitagrand 20
|
20 mg
|
Film-Coated Tablet
|
Antidepressant (Selective Serotonin Reuptake Inhibitor)
|
Ravian Life Science Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 March 2024
|
03 December 2024
|
| View |
|
DRP-5901-12
|
Ketoanalogues + Essential Amino Acids
|
Ketway
|
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
West Coast Pharmaceutical Works Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
17 December 2029
|
| View |
|
DRP-5901-13
|
Ketoanalogues + Essential Amino Acids
|
Protek-GFR
|
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
West Coast Pharmaceutical Works Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
17 December 2029
|
| View |
|
DRP-5948-03
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Piptabac 4.5
|
4 g/ 500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial
|
Inject Care Parenterals Pvt. Ltd.
|
|
CLIDP Conversion
|
25 March 2024
|
21 January 2025
|
| View |
|
DRP-5966-26
|
Co-Amoxiclav
|
Duoxiclav
|
457 mg/5 mL
|
Powder for Suspension
|
Antibacterial
|
Giyaan Pharma Private Limited
|
India
|
Renewal
|
07 May 2024
|
27 January 2030
|
| View |
|
DRP-5968-10
|
Hydrocortisone (as sodium succinate)
|
Hydrozen
|
250 mg
|
Powder for Injection (IM/IV)
|
Corticosteroid
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 March 2024
|
29 January 2025
|
| View |
|
DRP-5968-11
|
Hydrocortisone (as sodium succinate)
|
Aecor-250
|
250 mg
|
Powder for Injection (IM/IV)
|
Corticosteroid
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 March 2024
|
29 January 2025
|
| View |
|
DRP-6051-29
|
Ketoanalogues + Essential Amino Acids
|
Unbranded
|
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
04 August 2024
|
13 March 2030
|
| View |
|
DRP-6176-04
|
Telmisartan
|
Telmispec
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Hizon Laboratories, Inc
|
Philippines
|
Renewal
|
12 October 2024
|
23 January 2030
|
| View |
|
DRP-6261-03
|
Pantoprazole (as sodium sesquihydrate)
|
Pantonixx
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Opsonin Pharma Limited
|
Bangladesh
|
CLIDP Conversion
|
16 March 2024
|
09 February 2025
|
| View |
|
DRP-6341-05
|
Atorvastatin (as Calcium)
|
Atorpel
|
80 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
28 March 2024
|
11 September 2025
|
| View |
|
DRP-6492-11
|
Paracetamol + Orphenadrine citrate
|
Philgesic Forte
|
650 mg/ 35 mg
|
Film-Coated Tablet
|
Analgesic / Antipyretic / Muscle Relaxant
|
XL Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
18 January 2026
|
| View |
|
DRP-6702-04
|
Co-Amoxiclav
|
Cluvmox
|
625 mg
|
Film-Coated Tablet
|
Antibacterial ( Penicillin)
|
Yeluri Formulations Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 March 2024
|
24 February 2026
|
| View |
|
DRP-6758-20
|
Paracetamol + Vitamin B-Complex
|
Jandhar Plus
|
500 mg / 50 mg /100 mg / 100 mcg
|
Film-Coated Tablet
|
Analgesic / Antipyretic / Vitamin
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
25 March 2024
|
18 February 2029
|
| View |
|
DRP-6790-07
|
Multivitamins + Dextrose
|
Multamin
|
(see reverse page for formulation)
|
Solution for Injection (I.V. Infusion)
|
Parenteral Nutrition
|
Shijiazhuang No. 4 Pharmaceutical
|
China
|
CLIDP Conversion
|
17 March 2024
|
07 November 2028
|
| View |
|
DRP-7269-02
|
Levothyroxine (as Sodium)
|
Forhypo
|
25 mcg
|
Tablet
|
Thyroid Hormone Replacement
|
Steril-Gene Life Sciences (P) Ltd
|
India
|
CLIDP Conversion
|
19 March 2024
|
26 May 2029
|
| View |
|
DRP-7270-03
|
Levothyroxine (as Sodium)
|
Forhypo
|
50 mcg
|
Tablet
|
Thyroid Hormone Replacement
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
CLIDP Conversion
|
05 April 2024
|
30 July 2029
|
| View |
|
DRP-7631-01
|
Pregabalin
|
Algabin 75
|
75 mg
|
Capsule
|
Antiepileptic
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
04 April 2024
|
23 September 2026
|